Track the Pharmanutra PHN stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares trade on IT IT, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra PHN has logged 11 reports. Market capitalisation: €861.8m. The latest transaction was disclosed on 8 September 2025 (Other). Among the most active insiders: Unknown. All data is openly available.
Analysts rate Pharmanutra PHN Strong Buy (bullish), based on 3 analysts. Average price target: €81.33.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations